HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gary J Grover Selected Research

BMS 191095

2/2005Mitochondrial KATP channels in hindlimb remote ischemic preconditioning of skeletal muscle against infarction.
12/2003Protective effect of mitochondrial KATP activation in an isolated gracilis model of ischemia and reperfusion in dogs.
10/2002In vivo characterization of the mitochondrial selective K(ATP) opener (3R)-trans-4-((4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril monohydrochloride (BMS-191095): cardioprotective, hemodynamic, and electrophysiological effects.
1/2002Pharmacologic profile of the selective mitochondrial-K(ATP) opener BMS-191095 for treatment of acute myocardial ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gary J Grover Research Topics

Disease

7Ischemia
01/2008 - 08/2002
6Obesity
01/2012 - 08/2003
6Body Weight (Weight, Body)
04/2011 - 08/2003
5Infarction (Infarctions)
02/2005 - 08/2002
4Tachycardia (Tachyarrhythmias)
09/2008 - 04/2004
3Hyperglycemia
03/2014 - 10/2012
3Insulin Resistance
07/2013 - 09/2008
3Hypercholesterolemia
09/2008 - 08/2003
3Heart Arrest (Cardiac Arrest)
12/2003 - 04/2002
2Heart Diseases (Heart Disease)
01/2012 - 01/2009
2Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2008 - 01/2005
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2008 - 01/2002
2Hyperlipidemias (Hyperlipidemia)
04/2007 - 08/2003
1Hyperinsulinism (Hyperinsulinemia)
07/2013
1Non-alcoholic Fatty Liver Disease
07/2013
1Type 2 Diabetes Mellitus (MODY)
10/2012
1Alzheimer Disease (Alzheimer's Disease)
06/2011
1Neuroblastoma
06/2011
1Weight Gain
04/2011
1Hypertriglyceridemia
04/2011
1Thyrotoxicosis
01/2009
1Hyperthyroidism
01/2009
1Cardiac Arrhythmias (Arrythmia)
01/2009
1Weight Loss (Weight Reduction)
09/2008
1Cardiomegaly (Heart Hypertrophy)
04/2007
1Atrophy
03/2006
1Muscular Atrophy (Muscle Atrophy)
03/2006
1Reperfusion Injury
02/2005
1Necrosis
10/2004

Drug/Important Bio-Agent (IBA)

8Adenosine Triphosphate (ATP)IBA
01/2008 - 01/2002
6Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
07/2013 - 08/2003
5CholesterolIBA
09/2008 - 08/2003
4LipidsIBA
07/2013 - 04/2004
4Thyroid HormonesIBA
01/2009 - 01/2005
4KB 141IBA
09/2008 - 08/2003
45-hydroxydecanoic acidIBA
02/2005 - 04/2002
4BMS 191095IBA
02/2005 - 01/2002
4N- cyano- N'- (1,1- dimethylpropyl)- N''- (3- pyridinyl)guanidineIBA
12/2003 - 04/2002
3Glucose (Dextrose)FDA LinkGeneric
07/2013 - 09/2008
3BMS199264IBA
01/2008 - 10/2004
3OligomycinsIBA
01/2008 - 10/2004
3Thyroid Hormone Receptors beta (TR beta)IBA
04/2007 - 08/2003
3Glyburide (Glibenclamide)FDA LinkGeneric
02/2005 - 04/2002
2Polysaccharides (Glycans)IBA
03/2014 - 10/2012
2Sitagliptin Phosphate (Januvia)FDA Link
03/2014 - 10/2012
2GC 1 compoundIBA
07/2013 - 04/2004
2Triglycerides (Triacylglycerol)IBA
07/2013 - 09/2008
2Hormones (Hormone)IBA
10/2012 - 01/2005
2LDL CholesterolIBA
01/2012 - 04/2004
2Triiodothyronine (Liothyronine)FDA LinkGeneric
06/2011 - 09/2008
2CelluloseIBA
04/2011 - 02/2011
2Adenosine Triphosphatases (ATPase)IBA
01/2008 - 10/2004
2AurovertinsIBA
01/2008 - 10/2004
2aurovertin BIBA
01/2008 - 01/2008
2HydrolasesIBA
01/2008 - 10/2004
2HMR 1098IBA
02/2005 - 07/2003
2KATP ChannelsIBA
02/2005 - 12/2003
2Lipoprotein(a)IBA
04/2004 - 08/2003
2Phosphocreatine (Neoton)IBA
12/2003 - 07/2003
2Electron Transport Complex IV (Cytochrome c Oxidase)IBA
12/2003 - 07/2003
1Metformin (Glucophage)FDA LinkGeneric
03/2014
1PolyGlycoplexIBA
03/2014
13- ((3,5- dibromo- 4- (4- hydroxy- 3- (1- methylethyl)phenoxy)phenyl)amino)- 3- oxopropanoic acidIBA
07/2013
1Pharmaceutical PreparationsIBA
01/2012
1Proteins (Proteins, Gene)FDA Link
06/2011
1Amyloid (Amyloid Fibrils)IBA
06/2011
1ChromatinIBA
06/2011
1ElementsIBA
06/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
06/2011
1Sucrose (Saccharose)IBA
04/2011
1InulinFDA Link
02/2011
1Glucagon-Like Peptides (Enteroglucagon)IBA
02/2011
1MannansIBA
02/2011
1Glucagon-Like Peptide 1 (GLP 1)IBA
02/2011
1Insulin (Novolin)FDA Link
02/2011
1LigandsIBA
01/2009
1LithiumIBA
01/2009
1Nonesterified Fatty Acids (NEFA)IBA
09/2008
1oligomycin BIBA
01/2008
1UbiquitinIBA
03/2006
1Testosterone (Sustanon)FDA Link
03/2006
1Bortezomib (Velcade)FDA Link
03/2006
1Proteasome InhibitorsIBA
03/2006
1Proteasome Endopeptidase Complex (Proteasome)IBA
03/2006
1Peroxidase (Myeloperoxidase)IBA
02/2005
1Dihydrotachysterol (AT 10)IBA
02/2005
1PotassiumIBA
02/2005
1Proton-Translocating ATPases (ATPase, H+)IBA
10/2004
1Verapamil (Calan)FDA LinkGeneric
12/2003
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
12/2003
1RubidiumIBA
12/2003
1lipoprotein cholesterolIBA
08/2003
1Oxygen (Dioxygen)IBA
07/2003

Therapy/Procedure

4Therapeutics
10/2012 - 08/2003
1Glycemic Control
02/2011
1Denervation
03/2006
1Castration
03/2006
1Tourniquets
02/2005
1Intravenous Injections
02/2005
1Drug Therapy (Chemotherapy)
04/2004